Financing, Equity Capital Markets

TapImmune, Inc. nka Marker Therapeutics

10/18
|
$70.0 Million
Piper Sandler served as sole agent for TapImmune, Inc. on a PIPE offering
Sub-Type
PIPE
Sub-Sector
Biopharma